500mg Abiraterone Acetate Tablets IP

500mg Abiraterone Acetate Tablets IP Specification

Brand Name
XYTERONE-500

Salt Composition
Abiraterone Acetate 500 mg

Life Span
24 months from date of manufacture

Dosage Form
Tablet

Pacakaging (Quantity Per Box)
1 bottle of 120 tablets

Packaging Type
Bottle

Origin of Medicine
India

Indication
Prostate cancer

Drug Type
Allopathic

Ingredients
Abiraterone Acetate IP

Physical Form
Tablet, Tablets

Function
Anti-cancer medication

Recommended For
Treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Dosage
As directed by the physician

Dosage Guidelines
Take on an empty stomach, at least 1 hour before or 2 hours after eating

Suitable For
Adults only, Adults, especially males with prostate cancer

Quantity
120 tablets

Storage Instructions
Store below 30C, protect from moisture

Market Formulation
Film-coated tablet

Shape
Oval

Warning and Precautions
Not to be handled by women who are or may become pregnant

Side Effects
Hypokalemia, hypertension, joint swelling, fluid retention

Strength
500mg

Administration Route
Oral

Registration Status
WHO-GMP, ISO certified

Prescription/Non prescription
Prescription

Color
White to off-white

500mg Abiraterone Acetate Tablets IP Trade Information

Minimum Order Quantity
10 Boxes

Payment Terms
Cash Against Delivery (CAD), Cash on Delivery (COD), Cash in Advance (CID)

Supply Ability
100 Boxes Per Month

Delivery Time
5-7 Days

Main Domestic Market
All India

About 500mg Abiraterone Acetate Tablets IP

Introducing XYTERONE-500, the hot-selling new release in anti-cancer therapeutics. Each film-coated oval tablet delivers a masterful 500mg dose of Abiraterone Acetate IP, offering ravishing and unparalleled support for adults, especially males, battling metastatic castration-resistant prostate cancer (mCRPC). As a prescription-only, WHO-GMP and ISO-certified product from India, XYTERONE-500 reassures with its superior formulation. Reserve this product now to ensure access to exceptional efficacy. Caution: Not for handling by women who are or may become pregnant. Each bottle comes packed with 120 tablets, promising reliable quality with a 24-month shelf life.

Application Areas and Features of 500mg Abiraterone Acetate Tablets IP

XYTERONE-500 is expertly tailored for the treatment of metastatic castration-resistant prostate cancer (mCRPC) in adults. The tablet's unparalleled efficacy distinguishes it as a preferred hormone therapy in oncology. Used for oncological interventions, its film-coated design ensures optimal release, while the bottle packaging keeps tablets moisture-free. The product's robust WHO-GMP and ISO certifications affirm its premium quality, and its oral administration streamlines use for healthcare professionals and patients alike.

Supply Ability, Distribution, and Sample Policy of XYTERONE-500

XYTERONE-500 benefits from streamlined goods transport, ensuring rapid and secure delivery across the main domestic markets in India. The product is handed over to reliable freight partners for prompt distribution, guaranteeing each consignment is tracked and protected. A clear sample policy is in place for suppliers and traders, making it easier to review and assess the product quality before placing large-scale orders. Our extensive network ensures supply ability aligns smoothly with market demands.

FAQ's of 500mg Abiraterone Acetate Tablets IP:

Q: How should XYTERONE-500 be taken for optimal results?

A: XYTERONE-500 tablets should be taken orally on an empty stomach, at least 1 hour before or 2 hours after meals, as directed by your physician. Adhering to this guideline optimizes absorption and efficacy.

Q: What are the key benefits of using 500mg Abiraterone Acetate Tablets IP?

A: This medication is acclaimed for its unparalleled effectiveness in hormone therapy for adults with metastatic castration-resistant prostate cancer, providing improved disease management and patient outcomes.

Q: What precautions should be observed before handling XYTERONE-500?

A: Women who are or may become pregnant should not handle these tablets due to the risk of exposure. The medication is intended only for adult males diagnosed with appropriate prostate cancers.

Q: Where is XYTERONE-500 manufactured and what certifications does it have?

A: XYTERONE-500 is proudly manufactured in India and holds both WHO-GMP and ISO certifications, confirming its commitment to international quality and safety standards.

Q: When is it recommended to start using this medication for prostate cancer?

A: XYTERONE-500 is recommended for patients diagnosed with metastatic castration-resistant prostate cancer, following a physician's assessment and prescription. Dosage and duration are determined by the treating doctor.

Q: What is the best way to store the tablets to maintain efficacy?

A: Store XYTERONE-500 tablets below 30C, protected from moisture, and within the original bottle packaging to preserve their quality and effectiveness throughout the 24-month shelf life.